Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Baird Medical Investment Holdings Limited (BDMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: BDMD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -20.62% | Avg. Invested days 65 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 234.17M USD | Price to earnings Ratio 18.4 | 1Y Target Price - |
Price to earnings Ratio 18.4 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.7 | 52 Weeks Range 1.05 - 12.75 | Updated Date 06/3/2025 |
52 Weeks Range 1.05 - 12.75 | Updated Date 06/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.35 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 37.96% | Operating Margin (TTM) 38.74% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 18.4 | Forward PE - | Enterprise Value 248186805 | Price to Sales(TTM) 7.09 |
Enterprise Value 248186805 | Price to Sales(TTM) 7.09 | ||
Enterprise Value to Revenue 7.51 | Enterprise Value to EBITDA 15.25 | Shares Outstanding 36362200 | Shares Floating 10638416 |
Shares Outstanding 36362200 | Shares Floating 10638416 | ||
Percent Insiders 22.16 | Percent Institutions 1.97 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Baird Medical Investment Holdings Limited
Company Overview
History and Background
Baird Medical Investment Holdings Limited is a company operating in the medical sector. Information on the founding year and milestones is currently difficult to find.
Core Business Areas
- Medical Device Sales: Sales and distribution of various medical devices across different therapeutic areas.
- Healthcare Services: Provision of healthcare services, possibly including diagnostics and treatments. Specific services are not currently documented.
Leadership and Structure
Specific details about the leadership team and organizational structure are not widely available.
Top Products and Market Share
Key Offerings
- Medical Imaging Devices: Likely includes MRI machines, CT scanners, and X-ray equipment. Data on market share for this specific product is unavailable. Competitors include General Electric (GE), Siemens Healthineers (SIE.DE), and Philips (PHG).
- Surgical Instruments: Includes a range of surgical tools and equipment. Market share data for this product is not publicly available. Competitors include Medtronic (MDT), Johnson & Johnson (JNJ), and Stryker (SYK).
Market Dynamics
Industry Overview
The medical device industry is experiencing growth driven by an aging population, technological advancements, and increasing healthcare spending. The healthcare services industry is evolving with a growing focus on value-based care and telehealth.
Positioning
Baird Medical Investment Holdings Limited's positioning within the industry is difficult to determine precisely without more information about its key offerings and market share. They likely operate as a distributor or manufacturer within a specific niche.
Total Addressable Market (TAM)
TAM for the global medical device and healthcare services market is estimated to be in the trillions of dollars. Baird Medical Investment Holdings Limited's TAM would depend on its specific products and market segments.
Upturn SWOT Analysis
Strengths
- Established distribution network (assumed)
- Diverse product portfolio (assumed)
- Strong relationships with healthcare providers (assumed)
Weaknesses
- Limited brand recognition
- Dependence on third-party manufacturers (assumed)
- Lack of proprietary technology (assumed)
Opportunities
- Expansion into emerging markets
- Development of innovative medical devices
- Strategic partnerships with other healthcare companies
Threats
- Increasing competition
- Regulatory changes
- Economic downturns
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Johnson & Johnson (JNJ)
- Stryker (SYK)
- General Electric (GE)
Competitive Landscape
Baird Medical Investment Holdings Limited likely faces strong competition from larger, more established companies. Its competitive advantage may lie in specialized products or regional focus. Without more info, it is hard to state with certainty.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be assessed without financial data.
Future Projections: Future growth projections are not available without analyst estimates.
Recent Initiatives: Information on recent strategic initiatives is not readily available.
Summary
Baird Medical Investment Holdings Limited, operating in the competitive medical sector, lacks publicly available detailed information, hindering a comprehensive analysis. Strengths likely reside in its distribution and relationships. Weaknesses might be a smaller brand footprint and reliance on others. Further insights into financials, strategy, and competitive positioning are needed to determine its overall strength.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website (if available)
- Industry reports
- General market research
- Public financial data sources for competitors
Disclaimers:
The information provided is based on limited publicly available data and general market knowledge. Some data points are based on assumptions. Market share is estimates based on high-level sector information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Baird Medical Investment Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-10-01 | Chairwoman of the Board of Directors & CEO Ms. Haimei Wu | ||
Sector Healthcare | Industry Medical Devices | Full time employees 143 | Website https://bairdmed.com |
Full time employees 143 | Website https://bairdmed.com | ||
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. It offers microwave ablation apparatus and needles, as well as microwave ablation apparatus approved for the treatment of live cancer and thyroid nodules, long microwave ablation needles, and fine microwave ablation needles through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.